Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Allergy, 2022T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19
Taeschler P., Adamo S., Deng Y. et al.
Olink Target 96
Scientific Reports, 2022Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation
Oliveras T., Revuelta-López E., García-García C. et al.
Frontiers in Immunology, 2022The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
Kuijpers Y., Chu X., Jaeger M. et al.
The Journal of Infectious Diseases, 2022Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy
Kolossváry M., deFilippi C., Lu M. et al.
Proteomes, 2022Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
Mukherjee A., Pednekar C., Kolke S. et al.
American Journal of Respiratory Cell and Molecular Biology, 2022Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform
Mickael C., Kheyfets V., Langouët-Astrié C. et al.
Translational Psychiatry, 2022Metabolomics analysis of post-traumatic stress disorder symptoms in World Trade Center responders
Kuan P., Yang X., Kotov R. et al.
Frontiers in Aging Neuroscience, 2022The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the AppNL–G–F Model of Alzheimer’s Disease
Nieraad H., de Bruin N., Arne O. et al.
Olink Target 96 Mouse
European Stroke Journal, 2022A novel biomarker panel index improves risk stratification after ischemic stroke
Bicvic A., Scherrer N., Schweizer J. et al.
Nature Communications, 2022Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia
Huuhtanen J., Bhattacharya D., Lönnberg T. et al.
Circulation, 2022Genetic Landscape of the ACE2 Coronavirus Receptor
Yang Z., Macdonald-Dunlop E., Chen J. et al.
International Journal of Molecular Sciences, 2022Machine-Learning Analysis of Serum Proteomics in Neuropathic Pain after Nerve Injury in Breast Cancer Surgery Points at Chemokine Signaling via SIRT2 Regulation
Lötsch J., Mustonen L., Harno H. et al.
Human Molecular Genetics, 2022Meta-GWAS of PCSK9 levels detects two novel loci atAPOBandTM6SF2
Pott, J., Gådin et al.
Journal of Translational Medicine, 2022Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
Sims J., Poorbaugh J., Chang C. et al.
Scientific Reports, 2022Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions
Kopecky J., Pérez J., Eriksson H. et al.
Experimental Dermatology, 2022Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases
Vincken N., Welsing P., Silva‐Cardoso S. et al.
The Journal of Clinical Endocrinology & Metabolism, 2022Proteomic Profiles of Body Mass Index and Waist-to-Hip Ratio and Their Role in Incidence of Diabetes
Bao X., Xu B., Yin S. et al.
Stem Cell Research, 2022The proteome signature of cord blood plasma with high hematopoietic stem and progenitor cell count
Nilsson A., Rydbeck H., Thorsell A. et al.
Journal for ImmunoTherapy of Cancer, 2022Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Naing A., Powderly J., Nemunaitis J. et al.
Diabetes, 2022Connecting Genomics and Proteomics to Identify Protein Biomarkers for Adult and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study
Ghanbari F., Yazdanpanah N., Yazdanpanah M. et al.
2846 publications
Items per page
2181-2200 of 2846 publications